Results 121 to 130 of about 861,720 (342)
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto +8 more
wiley +1 more source
Permit requirements for energy and other natural resources for the State of Texas [PDF]
Radian Corp.
openalex +1 more source
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice +16 more
wiley +1 more source
Digital & Documentation 2024. Otherness
On September 16, the 2024 edition of the Digital & Documentation conference took place. Now in its 7th edition, the event brings together professors, researchers, and scholars in the field of Representation to discuss the topic related to documentation ...
Giuseppe Nicastro
doaj +1 more source
Potential therapeutic targeting of BKCa channels in glioblastoma treatment
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak +4 more
wiley +1 more source
Artificial intelligence and otherness
We cannot deny, for better or for worse, that the democratization and accessibility of artificial intelligence represent an epistemological, social and technical turning point in society.
Alexandre Provin Sbabo +1 more
doaj +1 more source
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source
SECOND PRIMARY GROWTHS IN THE REMAINING BREAST AFTER AMPUTATION OF THE OTHER FOR CARCINOMA [PDF]
David A. Drew
openalex +1 more source
Hearing voices: mental illness and cultural recognition [PDF]
Popular misconceptions about the danger of madness have undermined mentally ill people’s struggle for social inclusion. Consequently, efforts to think through how we might belong together must take account of mental patients’ right to a public voice ...
Cross, S, Lockyer, S
core

